IPP Bureau
HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
By IPP Bureau - October 12, 2021
HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs
Skanray to raise Rs 400 crore to fund its inorganic growth
By IPP Bureau - October 12, 2021
Since its inception, the company has either acquired or taken a majority stake in five companies
Tarsons earmarks funds from IPO to double capacity at its Panchla facility
By IPP Bureau - October 12, 2021
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Algorithm to calculate number of years one lives with good health
By IPP Bureau - October 12, 2021
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Medtronic’s robotic-assisted surgery system receives European CE mark
By IPP Bureau - October 12, 2021
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
LSNE expands lyophilization capacity at Madison, USA
By IPP Bureau - October 12, 2021
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
Everest Organics develops API for molnupiravir
By IPP Bureau - October 12, 2021
The drug is being developed at lab scale for the first-line of treatment of Covid-19
.jpg "Covaxin for kids gets nod, final approval awaited")
Covaxin for kids gets nod, final approval awaited
By IPP Bureau - October 12, 2021
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Intas launches the world's first SB-100mg Itraconazole
By IPP Bureau - October 12, 2021
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
Boehringer Ingelheim launches University of Medicine Excellence
By IPP Bureau - October 12, 2021
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
Glenmark launches Tavulus for COPD treatment in Spain
By IPP Bureau - October 11, 2021
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials
By IPP Bureau - October 11, 2021
VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
Astra’s antibody injection trial indicates it can prevent and treat Covid-19
By IPP Bureau - October 11, 2021
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
IDFC FIRST Bank & Banyan Academy launch Centre for Trauma Studies & Innovation
By IPP Bureau - October 11, 2021
Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels
HealthEdge opens its facility in Pune
By IPP Bureau - October 11, 2021
The Pune centre expands its presence beyond Bangalore and Hyderabad
